The transplacental transfer of cefuroxime was determined at antenatal fetal blood sampling in a cross sectional study of 78 patients between 15-35 weeks' gestation, 8-138 minutes after a maternal intravenous dose of 750 mg. Mean serum cefuroxime concentration, measured by high performance liquid chromatography, was 7-4 (95% confidence interval (CI) 6-8 to 8-1) mg/l in control fetuses; concentrations in hydropic fetuses were similar (6.2 mg/I, CI 4-7 to 7 7) but in fetuses with oligohydramnios they were significantly lower, (4.9 mg/I, CI 3-6 to 6-2). Antibiotic concentration did not correlate with gestational age and remained unchanged by transfusion of packed red cells. We conclude that (i) fetal serum concentrations of cefuroxime obtained after a maternal dose of 750 mg are only adequate for prophylaxis against organisms with a minimum inhibitory concentration of <4 mg/l and (ii) transplacental passage of cefuroxime is significantly reduced in the presence of oligohydramnios.
Infection in utero is implicated as a cause of premature rupture of the membranes and preterm labour.' With the increase in invasive procedures for fetal diagnosis and treatment, and their attendant risk of infection,2 there is renewed interest in the placental transfer of antibiotics used for prophylaxis or treatment.
Transplacental antibiotic treatment is based on the premise that a sufficient concentration will reach the intrauterine environment to treat or prevent infection; however there are few data to substantiate this. In several previous studies, concentrations of antibiotic were measured in cord blood at delivery after maternal administration of the antibiotic during labour,3 4 but this approach gives no indication of concentrations attained in fetal serum in utero. Little consideration has been given to the effects on transplacental transfer of such parameters as gestational age, hydrops, abnormal amniotic fluid volume, or procedures such as intravascular transfusion.
Cefuroxime has a broad spectrum bactericidal activity against organisms associated with intrauterine infections.5 It is relatively resistant to beta-lactamase degradation, well tolerated, and free from toxicity, making it suitable for use in pregnancy.
We therefore determined the extent to which a prophylactic dose of maternally administered cefuroxime was transferred to the fetus before antenatal fetal blood sampling in uncomplicated pregnancies and in those complicated by hydrops or abnormalities in amniotic fluid volume. Additionally, we determined the effect of gestational age and intravascular transfusion on the placental transfer of cefuroxime. n=15, mg/l, 95% CI 5-7 to 7-5 mgfl) and Cefuroxime concentrations were measured in Rh fetuses (group 2, n=38, 7-7 mg/l, by high performance liquid chromatography to 8-5 mg/l). As none of these fetuses had with a coefficient of variation of less than 4%.7 severe Rh alloimmunisation, for example none Statistical comparisons were performed with had hydrops or polyhydramnios and their paired and unpaired Student's t tests, while packed cell volumes were above the value norrelationships between variables were assessed mally associated with circulatory changes8 and changes in oxygenation,9 the two groups were therefore pooled (n=53, 7-4 mg/l, CI 6-8 to 8-1 mg/l) and used as controls for further concentration. Although the time span studied was limited, this may be indicative of a in fetal infection include those isolated from degree of fetal accumulation, as during that women with postpartum endometritis5 (that time the maternal serum concentrations of the is, Staphylococcus epidermidis, ax and P-antibiotic decreased exponentially from haemolytic streptococci, and anaerobic strep-around 60 mg/l to 10 mg/l (DE Holt et al, tococci) and those from women with acute unpublished data) in accordance with its chorioamnionitis'0 (that is, group B strepto-known pharmacological properties.3 In adults coccus and Escherichia colt). In a study of 67 cefuroxime is excreted almost entirely by the patients with intra-amniotic infection,'0 group kidneys. Although the fetal kidney is partly B streptococci were isolated from 25% of functional by the 12th week of gestation, cases, along with E coli (21%), a-streptococci glomerular filtration rate and tubular function (15%), and Kiebsiella pneumoniae (4%/o). In continue to mature well into the third addition Staphylococcus aureus and a-trimester. MICs between 4 and 16 mg/1,'3 and only 50/o cephalosporin cefazolin.21 Also, with the third of klebsiella strains have an MIC <31 mg/1.14 generation cephalosporin ceftizoxime, fetal While our study demonstrates that cefuroxime concentrations are continuously higher than crosses the placenta during the second and maternal concentrations when a pharmacokithird trimester to reach concentrations in fetal netic steady state is reached.22 serum which exceed the MIC for some organ-
Patients and methods
We were unable to demonstrate a signifiisms associated with intrauterine infection, cant relationship between the transplacental only five fetuses attained serum concentra-passage of cefuroxime and gestational age. tions of cefuroxime >12 mg/l. It is therefore Likewise, intravascular transfusion of packed likely that higher maternal doses would be red cells had no effect on fetal serum concenrequired to achieve adequate fetal concentra-trations of cefuroxime. In these cases equilibtions against E coli or klebsiella.
rium occurs very quickly, presumably from In the presence of hydrops with polyhy-fetal tissues or the maternal circulation. Most dramnios there was no reduction in the pla-of the volume of fluid transfused during the cental transfer of cefuroxime. In contrast, in procedure is rapidly cleared across the placenoligohydramnios, fetal serum concentrations ta, therefore the fetal intravascular volume is of the antibiotic were significantly reduced. likely to remain unchanged. 23 In neonatal toxThis decrease in cefuroxime transfer may icity caused by chloramphenicol, transfusion reflect reduced placental function in pregnan-has only a minimal effect on the serum concies complicated by this condition and sug-centration of the antibiotic. 24 Multiple gests that these fetuses may not be adequately exchange transfusions or charcoal haemoperprotected by a single maternal dose of 750 fusion are necessary to reduce antibiotic conmg. This could be particularly important in centrations.25 cases of oligohydramnios where amnioinfuWe have demonstrated that cefuroxime sion, with its attendant risk of introducing crosses the placenta, unaffected by gestational infection, is used for diagnosis and treat-age or packed red cell transfusion, to achieve a ment. ' attained concentrations >12 mg/l that would be reliably effective against organisms with MICs of 4 mg/l or more, however, suggests that for prophylaxis against some strains of common organisms an increase in dose would be necessary. Fetal serum concentrations of cefuroxime in oligohydramnios are significantly reduced, therefore in these cases a change in regimen might be considered. Further studies are in progress to determine the fetal uptake of an increased dose of cefuroxime. 
